Articles with public access mandates - Stallings RLLearn more
Not available anywhere: 13
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
JJ Molenaar, R Domingo-Fernández, ME Ebus, S Lindner, J Koster, ...
Nature genetics 44 (11), 1199-1206, 2012
Mandates: US National Institutes of Health, Science Foundation Ireland
MiR‐137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A
K Althoff, A Beckers, A Odersky, P Mestdagh, J Köster, IM Bray, K Bryan, ...
International journal of cancer 133 (5), 1064-1073, 2013
Mandates: US National Institutes of Health, Science Foundation Ireland
Modulation of chemotherapeutic drug resistance in neuroblastoma SK‐N‐AS cells by the neural apoptosis inhibitory protein and mi R‐520f
H Harvey, O Piskareva, L Creevey, LC Alcock, PG Buckley, MJ O'Sullivan, ...
International journal of cancer 136 (7), 1579-1588, 2015
Mandates: US National Institutes of Health, Health Research Board, Ireland, Science …
Genome‐wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large‐scale epigenomic alterations localized to telomeric regions
PG Buckley, S Das, K Bryan, KM Watters, L Alcock, J Koster, R Versteeg, ...
International Journal of cancer 128 (10), 2296-2305, 2011
Mandates: US National Institutes of Health, Science Foundation Ireland
Therapeutic targeting of miRNAs in neuroblastoma
RL Stallings, NH Foley, K Bryan, PG Buckley, I Bray
Expert opinion on therapeutic targets 14 (9), 951-962, 2010
Mandates: US National Institutes of Health, Science Foundation Ireland
Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis
DM Murphy, PG Buckley, K Bryan, KM Watters, J Koster, P van Sluis, ...
Molecular carcinogenesis 50 (6), 403-411, 2011
Mandates: US National Institutes of Health, Science Foundation Ireland
New insights into the genetics of Neuroblastoma: Implications for diagnosis and therapy
S Sridhar, B Al-Moallem, H Kamal, M Terrile, RL Stallings
Molecular diagnosis & therapy 17, 63-69, 2013
Mandates: US National Institutes of Health, Science Foundation Ireland
Increased frequencies of the killer immunoglobulin‐like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma
SE Keating, C Ní Chorcora, MM Dring, RL Stallings, A O'Meara, ...
Tissue Antigens 86 (3), 172-177, 2015
Mandates: Cancer Research UK
Triangular silver nanoplates: properties and ultrasensitive detection of miRNA
H McArdle, E Spain, TE Keyes, RL Stallings, M Brennan-Fournet, ...
Electrochemistry Communications 79, 23-27, 2017
Mandates: Science Foundation Ireland
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma
A Rihani, T Van Maerken, B De Wilde, F Zeka, G Laureys, K Norga, ...
Pediatric blood & cancer 61 (10), 1867-1870, 2014
Mandates: Research Foundation (Flanders), Government of Spain
Hemispherical platinum: silver core: shell nanoparticles for miRNA detection
E Spain, K Adamson, M Elshahawy, I Bray, TE Keyes, RL Stallings, ...
Analyst 142 (5), 752-762, 2017
Mandates: Science Foundation Ireland
Organization and amplification of metallothionein genes in eukaryotic cells
CE Hildebrand, DL Grady, RL Stallings
Gene Amplification in Mammalian Cells, 185-194, 2020
Mandates: US Department of Energy
Investigating Gene Promoter Methylation in a Mouse Model of Status Epilepticus
SFC Miller-Delaney, S Das, RL Stallings, DC Henshall
Tiling Arrays: Methods and Protocols, 87-101, 2013
Mandates: Science Foundation Ireland
Available somewhere: 47
Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects
EM Jimenez-Mateos, T Engel, P Merino-Serrais, RC McKiernan, ...
Nature medicine 18 (7), 1087-1094, 2012
Mandates: US National Institutes of Health, Science Foundation Ireland, Government of …
Rare deletions at 16p13. 11 predispose to a diverse spectrum of sporadic epilepsy syndromes
EL Heinzen, RA Radtke, TJ Urban, GL Cavalleri, C Depondt, AC Need, ...
The American Journal of Human Genetics 86 (5), 707-718, 2010
Mandates: Higher Education Authority, Ireland
Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles
A Tivnan, WS Orr, V Gubala, R Nooney, DE Williams, C McDonagh, ...
PloS one 7 (5), e38129, 2012
Mandates: US National Institutes of Health, Science Foundation Ireland
miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132
EM Jimenez-Mateos, I Bray, A Sanz-Rodriguez, T Engel, RC McKiernan, ...
The American journal of pathology 179 (5), 2519-2532, 2011
Mandates: US National Institutes of Health, Science Foundation Ireland
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2
NH Foley, IM Bray, A Tivnan, K Bryan, DM Murphy, PG Buckley, J Ryan, ...
Molecular cancer 9, 1-11, 2010
Mandates: US National Institutes of Health, Science Foundation Ireland
MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway
J Lynch, J Fay, M Meehan, K Bryan, KM Watters, DM Murphy, RL Stallings
Carcinogenesis 33 (5), 976-985, 2012
Mandates: US National Institutes of Health, Science Foundation Ireland
Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy
SFC Miller-Delaney, K Bryan, S Das, RC McKiernan, IM Bray, ...
Brain 138 (3), 616-631, 2015
Mandates: Health Research Board, Ireland, Science Foundation Ireland
Publication and funding information is determined automatically by a computer program